Helomics Corp:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Helomics Corp - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6639
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Helomics Corp (Helomics) is a life science company that develops and offers precision medicine support tools and services for cancer treatment. The company’s products include chemofx, biospecifx, genefx colon and genefx lung. Its chemofx is a drug response marker, which is used to test tumor response to various chemotherapeutic and biologic agents. Helomics’ biospecifx is a biomarker that is used to test drug response and patient prognosis. The company also offers contract research, genefx colon, which is a microarray-based gene signature that identifies patients at risk of recurrence. It serves clinical testing, precision medicine and cancer research needs of physicians. The company has operations in US and Canada. Precision is headquartered in Pittsburgh, Pennsylvania, the US.

Helomics Corp – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Helomics Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Helomics Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Helomics Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Helomics Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Helomics Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Helomics Corp, Medical Equipment, Deal Details 10
Venture Financing 10
Precision Therapeutics Raises US$14 Million In Venture Financing 10
Private Equity 11
Healthcare Royalty Invests USD60 Million in Precision Therapeutics 11
Partnerships 12
Skyline Medical Forms Joint Venture with Helomics 12
Skyline Medical and Helomics Enter into Partnership 13
Helomics Partners with MDNA Life Sciences 14
Acquisition 15
Precision Therapeutics to Acquire Remaining 75% Stake in Helomics 15
Precision Therapeutics Acquires 25% Stake in Helomics 16
Helomics Corp – Key Competitors 17
Helomics Corp – Key Employees 18
Helomics Corp – Locations And Subsidiaries 19
Head Office 19
Recent Developments 20
Strategy And Business Planning 20
Jun 01, 2017: Helomics and the Pittsburgh Life Sciences Greenhouse Partner to Establish a Biotechnology Incubator Dedicated to Diagnostics and Precision Medicine 20
Corporate Communications 21
Jan 10, 2018: Helomics Announces the appointment of Dr. Marc Malandro to its Advisory Board, providing strategic insights for the Skyline Medical – Helomics Joint Venture 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Helomics Corp, Medical Equipment, Key Facts 2
Helomics Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Helomics Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Helomics Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Helomics Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Helomics Corp, Deals By Market, 2012 to YTD 2018 8
Helomics Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Precision Therapeutics Raises US$14 Million In Venture Financing 10
Healthcare Royalty Invests USD60 Million in Precision Therapeutics 11
Skyline Medical Forms Joint Venture with Helomics 12
Skyline Medical and Helomics Enter into Partnership 13
Helomics Partners with MDNA Life Sciences 14
Precision Therapeutics to Acquire Remaining 75% Stake in Helomics 15
Precision Therapeutics Acquires 25% Stake in Helomics 16
Helomics Corp, Key Competitors 17
Helomics Corp, Key Employees 18

List of Figures
Helomics Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Helomics Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Helomics Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Helomics Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Helomics Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Helomics Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Helomics Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Helomics Corp:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Taiflex Scientific Co., Ltd. (8039):企業の財務・戦略的SWOT分析
    Taiflex Scientific Co., Ltd. (8039) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Asahi Intecc Co Ltd (7747):企業の財務・戦略的SWOT分析
    Summary Asahi Intecc Co Ltd (Asahi) is a medical device company that develops, manufactures and markets terminal processed products. The company provides medical components such as guide wires, balloon catheters, guiding catheters, penetration catheters, peripheral guide wires, IVR guide wires and m …
  • Omega Diagnostics Group Plc (ODX):企業の財務・戦略的SWOT分析
    Summary Omega Diagnostics Group Plc (Omega) is a biotechnology company that provides in-vitro diagnostic products. The company provides products in the areas of allergy, food intolerance, autoimmune disease and infectious disease, among others. It also provides food intolerance and autoimmune tests …
  • Orlando Utilities Commission:電力:M&Aディール及び事業提携情報
    Summary Orlando Utilities Commission (OUC) is a municipally-owned public utility that provides water and electric services. The commission generates, transmits, and distributes electricity and water to residential and commercial customers. It also constructs, operates and maintains electric and wate …
  • Sunrise Senior Living LLC:戦略・SWOT・企業財務分析
    Sunrise Senior Living LLC - Strategy, SWOT and Corporate Finance Report Summary Sunrise Senior Living LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • GENTEX Corp:企業の戦略的SWOT分析
    GENTEX Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Go-Ahead Group Plc:企業の戦略・SWOT・財務情報
    Go-Ahead Group Plc - Strategy, SWOT and Corporate Finance Report Summary Go-Ahead Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • National Bank of Canada:企業の戦略・SWOT・財務分析
    National Bank of Canada - Strategy, SWOT and Corporate Finance Report Summary National Bank of Canada - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Paratek Pharmaceuticals Inc (PRTK):製薬・医療:M&Aディール及び事業提携情報
    Summary Paratek Pharmaceuticals Inc (Paratek) is a biopharmaceutical company that develops and commercializes therapies based on tetracycline chemistry. Omadacycline (antibiotic), the company’s lead product candidate is an aminomethylcycline which acts against gram-negative, gram-positive, and atypi …
  • Camargo Correa Sa
    Camargo Correa Sa - Strategy, SWOT and Corporate Finance Report Summary Camargo Correa Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Global Imaging Systems, Inc.:企業のM&A・事業提携・投資動向
    Global Imaging Systems, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Global Imaging Systems, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • Sony Financial Holdings Inc.:企業の戦略・SWOT・財務情報
    Sony Financial Holdings Inc. - Strategy, SWOT and Corporate Finance Report Summary Sony Financial Holdings Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Itochu Techno-Solutions Corp (4739):企業の財務・戦略的SWOT分析
    Itochu Techno-Solutions Corp (4739) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • SHI International Corp.:企業の戦略的SWOT分析
    SHI International Corp. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • POET Technologies Inc (PTK):企業の財務・戦略的SWOT分析
    Summary POET Technologies Inc (POET), a subsidiary of Pinetree Capital Ltd, is a technology company that develops integrated circuit platforms. The company offers products such as narrow linewidth laser, broadband light sources, data communications products and active and passive components, among o …
  • Nestle USA, Inc.:企業の戦略・SWOT・財務情報
    Nestle USA, Inc. - Strategy, SWOT and Corporate Finance Report Summary Nestle USA, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • CIC Private Banking:企業の戦略・SWOT・財務情報
    CIC Private Banking - Strategy, SWOT and Corporate Finance Report Summary CIC Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Alphanosos SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary Alphanosos SAS (Alphanosos) is a developer of novel therapies for the treatment of chronic inflammatory diseases. The company offers pure antibiofilms and antibiotics. It concentrates on bacterial biofilms in various therapeutic areas such as dermatological, bucco-dental and respiratory dise …
  • AXIS Capital Holdings Limited:戦略・SWOT・企業財務分析
    AXIS Capital Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary AXIS Capital Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • BioRestorative Therapies Inc (BRTX):企業の財務・戦略的SWOT分析
    Summary BioRestorative Therapies Inc (BRT), formerly Stem Cell Assurance Inc is a developer of therapeutic products and medical therapies. The company performs stem cell programs which include brtxDISC and ThermoStem. brtxDISC,a lead therapeutic product, is designed to offer a non-surgical treatment …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆